These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2674856)
21. [K-ras gene mutation in gallbladder carcinoma]. Roa JC; Roa I; de Aretxabala X; Melo A; Faría G; Tapia O Rev Med Chil; 2004 Aug; 132(8):955-60. PubMed ID: 15478297 [TBL] [Abstract][Full Text] [Related]
22. Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy. Hongyo T; Buzard GS; Palli D; Weghorst CM; Amorosi A; Galli M; Caporaso NE; Fraumeni JF; Rice JM Cancer Res; 1995 Jun; 55(12):2665-72. PubMed ID: 7780983 [TBL] [Abstract][Full Text] [Related]
23. Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues. Keohavong P; Zhu D; Whiteside TL; Swalsky P; Bakker A; Elder EM; Siegfried JM; Srivastava S; Finkelstein SD Anal Biochem; 1997 May; 247(2):394-403. PubMed ID: 9177704 [TBL] [Abstract][Full Text] [Related]
24. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma. Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083 [TBL] [Abstract][Full Text] [Related]
25. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. DiGiuseppe JA; Hruban RH; Offerhaus GJ; Clement MJ; van den Berg FM; Cameron JL; van Mansfeld AD Am J Pathol; 1994 May; 144(5):889-95. PubMed ID: 8178941 [TBL] [Abstract][Full Text] [Related]
26. Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA. Marchese R; Muleti A; Pasqualetti P; Bucci B; Stigliano A; Brunetti E; De Angelis M; Mazzoni G; Tocchi A; Brozzetti S Pancreas; 2006 Mar; 32(2):171-7. PubMed ID: 16552337 [TBL] [Abstract][Full Text] [Related]
27. Coamplification at lower denaturation temperature polymerase chain reaction enables selective identification of K-Ras mutations in formalin-fixed, paraffin-embedded tumor tissues without tumor-cell enrichment. Yu S; Xie L; Hou Z; Qian X; Yu L; Wei J; Ding Y; Liu B Hum Pathol; 2011 Sep; 42(9):1312-8. PubMed ID: 21406308 [TBL] [Abstract][Full Text] [Related]
28. Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma. Lee J; Jang KT; Ki CS; Lim T; Park YS; Lim HY; Choi DW; Kang WK; Park K; Park JO Cancer; 2007 Apr; 109(8):1561-9. PubMed ID: 17354229 [TBL] [Abstract][Full Text] [Related]
29. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Tada M; Omata M; Kawai S; Saisho H; Ohto M; Saiki RK; Sninsky JJ Cancer Res; 1993 Jun; 53(11):2472-4. PubMed ID: 8495407 [TBL] [Abstract][Full Text] [Related]
30. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung. Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992 [TBL] [Abstract][Full Text] [Related]
31. P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas. Mueller J; Gansauge S; Mattfeldt T Hepatogastroenterology; 2003; 50(50):541-4. PubMed ID: 12749268 [TBL] [Abstract][Full Text] [Related]
32. Analysis of K-ras mutations in pancreatic tissue after fine needle aspirates. Pabst B; Arps S; Binmoeller K; Thul R; Walsemann G; Fenner C; Klapdor R Anticancer Res; 1999; 19(4A):2481-3. PubMed ID: 10470178 [TBL] [Abstract][Full Text] [Related]
34. Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer: comparison with K-ras mutation. Yamaguchi Y; Watanabe H; Yrdiran S; Ohtsubo K; Motoo Y; Okai T; Sawabu N Clin Cancer Res; 1999 May; 5(5):1147-53. PubMed ID: 10353750 [TBL] [Abstract][Full Text] [Related]
35. Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma. Rall CJ; Yan YX; Graeme-Cook F; Beauchamp R; Yandell DW; Povoski SP; Rustgi AK Pancreas; 1996 Jan; 12(1):10-7. PubMed ID: 8927612 [TBL] [Abstract][Full Text] [Related]
37. Reassessment of K-ras mutations at codon 12 by direct PCR and sequencing from tissue microdissection in human pancreatic adenocarcinomas. Aoki Y; Hosaka S; Tachibana N; Karasawa Y; Kawa S; Kiyosawa K Pancreas; 2000 Aug; 21(2):152-7. PubMed ID: 10975709 [TBL] [Abstract][Full Text] [Related]
38. ras oncogenes in human cancer: a review. Bos JL Cancer Res; 1989 Sep; 49(17):4682-9. PubMed ID: 2547513 [TBL] [Abstract][Full Text] [Related]
39. Analysis of c-Ki-ras mutations in human colon carcinoma by cell sorting, polymerase chain reaction, and DNA sequencing. Burmer GC; Rabinovitch PS; Loeb LA Cancer Res; 1989 Apr; 49(8):2141-6. PubMed ID: 2649235 [TBL] [Abstract][Full Text] [Related]
40. A two-step enriched-nested PCR technique enhances sensitivity for detection of codon 12 K-ras mutations in pancreatic adenocarcinoma. Banerjee SK; Makdisi WF; Weston AP; Campbell DR Pancreas; 1997 Jul; 15(1):16-24. PubMed ID: 9211488 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]